Fetroja Injection, Powder, For Solution
Product Images NDC 59630-266

2 FDA label images from Shionogi Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fetroja (NDC 59630-266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shionogi Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Fetroja 01)

Figure 1 (Fetroja 01)
Chemical structure of Cefiderocol sulfate tosylate, the active ingredient in Fetroja injection powder for solution, represented with molecular components including sulfate and hydrates.*
FDA Label Image

Principal Display Panel (1 gram Vial Carton)

Principal Display Panel (1 gram Vial Carton)
Packaging label for Fetroja 1 gram (cefiderocol) injection, powder for solution for intravenous infusion. The label shows the product name, strength, dosage form, route, and instructions stating it must be reconstituted then diluted. It contains 10 single-dose vials and is labeled by Shionogi Inc. The design features a geometric horse head logo with prominent red and blue color blocks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.